The Beauty Health Company

The Beauty Health Company

SKIN
The Beauty Health CompanyUS flagNASDAQ Capital Market
0.63
USD
-0.03
- -
82.15MMarket Cap

Total Valuation

The Beauty Health Company carries a market capitalization of 82.15M, placing it among publicly traded companies globally. Its enterprise value stands at 275.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap82.15M
Enterprise Value275.84M

Share Statistics

The Beauty Health Company currently has 129.14M shares outstanding.

Shares Outstanding129.14M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.38, and the price-to-book ratio stands at -0.22.

PE RatioN/A
PS Ratio0.38
PB Ratio-0.22
P/TBV Ratio-1.09
P/FCF Ratio3.38
P/OCF Ratio3.91

Enterprise Valuation

On an enterprise value basis, The Beauty Health Company trades at an EV/EBITDA multiple of 19.79 and an EV/FCF ratio of 3.72.

EV / Sales0.93
EV / EBITDA19.79
EV / EBITN/A
EV / FCF3.72

Financial Position

The Beauty Health Company maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 664.61, indicating elevated leverage, while an interest coverage ratio of 0.60 demonstrates limited ability to service its debt obligations.

Current Ratio1.79
Quick Ratio1.45
Debt / Equity664.61
Debt / EBITDA26.34
Interest Coverage0.60

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-1.06
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.83

Taxes

Income Tax2.51M
Effective Tax RateN/A

Stock Price Statistics

The Beauty Health Company's stock has declined approximately -61.58182% over the past 52 weeks. The 50-day moving average sits at 0.83, while the 200-day moving average is 1.36.

Beta (5Y)N/A
52-Week Price Change-61.58182%
50-Day Moving Average0.83
200-Day Moving Average1.36
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, The Beauty Health Company generated 296.12M in revenue and converted that into -6.05M in net income, yielding earnings per share of -0.05. EBITDA reached 13.94M, while operating income came in at -10.58M.

Revenue296.12M
Gross Profit192.22M
Operating Income-10.58M
Pretax Income-3.55M
Net Income-6.05M
EBITDA13.94M
EBIT-10.58M
Earnings Per Share (EPS)-0.05

Balance Sheet

The Beauty Health Company holds 204.36M in cash and equivalents against 367.13M in total debt, resulting in a net debt position of 139.86M. Total book value stands at -524.10M, with working capital of 122.49M providing operational flexibility.

Cash & Cash Equivalents204.36M
Total Debt367.13M
Net Debt139.86M
Equity (Book Value)-524.10M
Book Value Per Share-4.13
Working Capital122.49M

Cash Flow

The Beauty Health Company produced 28.94M in operating cash flow over the past twelve months. After subtracting -5.67M in capital expenditures, free cash flow totaled 23.27M - equivalent to 0.18 per share.

Operating Cash Flow28.94M
Capital Expenditures-5.67M
Free Cash Flow23.27M
FCF Per Share0.18

Margins

The Beauty Health Company operates with a gross margin of 64.91, reflecting its pricing power and cost economics. The operating margin of -3.57 and net profit margin of -2.04 provide insight into operational efficiency.

Gross Margin64.91
Operating Margin-3.57
Pretax Margin-1.20
Profit Margin-2.04
EBITDA Margin4.71

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield172.97
FCF Yield29.56

Scores

The Beauty Health Company posts an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.87